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The dose response curves of LVdPldt to Isoproterenol (0.025, 0.05, 0.1,
0.5I!glkg) were significantly shifted down and to the right after heart failure.
Clinical signs of heart failure such as protein wasting, dyspnea, edema and
ascites developed in all animals. Thus, an ischemic heart failure, as defined
by hemodynamic, pharmacological and clinical features, developed using
daily coronary embolization.
LVP(mmHg)
LVEDP (mmHg)
MAP (mmHg)
LAP (mmHg)
HR (beats/min)
LVdP/dt(mmHg/s)
Control
133 ± 6
3.8 ± 1.2
101 ± 2
5.8 ± 1
66 ± 9
3109 ± 665
3Wks of Embolization
106 ± 2'
14.2 ± 09'
87 ± 8
11.7 ± l'
138 ± 32
2281 ± 460'
lactate alanine free carnitine ATP
ADR 10 In = 6) 1572 ± 1.38 2.10 ± 023 1.05 ± 007 7.23±0.51
ADR 3W(n = 6) 3.47 ± 0.41 1.02 ± 0.24 0.83 ± 005 598 ± 0.16
ADR 6W(n ~ 6) 9.10 ± 0.76 1.28 ± 0.17 0.60 ± 007 4.70 ± 038
In ADR 1D, the tissue levels of lactate and alanine were significantly higher
than those of Control 1D (p < 0.05), although the tissue levels of free car-
nitine and ATP were preserved. However, in ADR 3W, the tissue levels of
free carnitine and ATP were significantly lower than those of Control 3W (p
< 0.05). The tissue levels of free carnitine and ATP appeared to be further
reduced in ADR 6W.
Conclusion; This study demonstrated that the impaired energy production
had already occurred even at early stage of ADR-induced heart failure.
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Left ventricular hypertrophy (LVH) predisposes to an increased infarct size af-
ter coronary occlusion in dog. Aim of the study was to investigate the impact
of the coexistence of LVH secondary to hypertension and coronary stenosis
on the coronary vasodilator capacity in man. Coronary flow velocity in left an-
terior descending artery (LAD) was monitored by Transesophageal-Doppler
at baseline and during low- and high-dose of Lv. Dipyridamole (0.56 mglKgl4
min followed after 2 min by 0.28 mglKgf2 min) in 56 patients, divided as fol-
lows: 19 normal controls (N Group), 21 pts with hypertension, LVH and no
CAD (LVH Group), and 16 pts with moderate LAD artery stenosis (~75%) [10
without LVH (LAD Group) and 6 with LVH secondary to hypertension (LAD
+ LVH Group)]. All pts had Dipyridamole Echo test negative for left ventric-
ular asynergy. Blood pressure and left ventricular mass were similar in N
vs LAD pts, and in LVH vs LAD + LVH. Mean total coronary flow velocity
was measured from Doppler recordings. Coronary reserve was computed
as the ratio of high-dose Dipyridamole to Basal flow velocity. Minimum coro-
nary resistance and the percent of coronary reserve recruited after low-dose
Dipyridamole were also computed.
Results: Baseline coronary flow velocity was 29 ± 6 cmlsec in N, and sig-
nificantly higher in LVH and CAD (39 ± 11 and 41 ± 11, respectively, p <
0.01). Coronary flow velocity after high·dose Dipyridamole was 92 ± 18 in
N, and significantly lower only in LAD + LVH (68 ± 16, p < 0.05). Coronary
reserve was 3.3 ± 0.7 in N, and significantly reduced in all pts subgroups (2.4
± 0.4, 2.2 ± 0.6, 2.3 ± 0.4 in LVH, LAD, LAD + LVH; P < 0.01 vs N). Percent
of coronary reserve recruited after low-dose Dipyridamole was 94 ± 8% in
N, 91 ± 11 % in LAD, and lower in LVH (79 ± 11 %, P < 0.01 vs N) and in LAD
+ LVH (69 ± 10%, P < 0.05 vs LVH). Compared to N, minimum coronary re-
sistance was significantly higher in LVH (p < 0.05) and LAD + LVH (p < 0.01)
(0.94 ± 0.2 vs 1.20 ± 0.3 and 1.40 ± 0.4 mmHglmllmin, respectively); it was
also higher in LAD + LVH than in LAD alone (1.07 ± 0.2 mmHglmlfmin, p <
0.05).
Conclusions: Coronary reserve is similarly reduced in pts with LVH sec-
ondary to hypertension, LAD stenosis alone, or LVH + LAD stenosis. Coex-
istence of hypertensive LVH with LAD stenosis is associated. compared to
LAD stenosis alone, with significantly higher minimum coronary resistance
and a hindered utilization of the reduced coronary reserve.
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Relationship Between Heart Chymase and ACE
Activity in Dogs with Volume Overload
Hypertrophy and Increased Cardiac Angiotensin
Peptide Levels
Eduardo Balcells, Oing C. Meng, Suzanne Oparil, Terry S. Elton,
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Myocardial Glycolytic and Fatty Acid Metabolism
During Progression of Adriamycin (ADR)-Induced
Heart Failure in Rats
Norio Kawasaki, Jong-Dae Lee, Akiyoshi Tsubokawa, Masayuki Yamamoto,
Hiromasa Shimizu, Takanori Ueda, Toru Nakamura. The First Department of Internal
Medicine, Fukui Medical School, Fukui, Japan
We have previously reported increased intracardiac angiotensin II (ANG II)
levels in a dog model of volume overload hypertrophy produced by percu-
taneous chordal rupture of the mitral valve. Whether the increase in ANG II
is mediated by angiotensin converting enzyme (ACE) andlor heart chymase
is unknown. Magnetic resonance imaging and high-fidelity pressure moni-
toring were performed on 8 adult mongrel dogs before and 5 months after
causing mitral regurgitation (MR). Left ventricular (LV) end-diastolic volume
increased from 58 ± 13 [SO] to 102 ± 35 ml (p < 0.001), as did end-systolic
volume (33 ± 10 to 47 ± 18 ml, p < 0.001). LV mass increased in all dogs
from 82 ± 22 to 112 ± 25 grams (p < 0.001) and the LV mass/end-diastolic
volume ratio decreased significantly from 1.63 ± 0.20 to 1.17 ± 0.23 gmlml
(p < 0.001). ANG II levels were significantly higher in the midwall of the left
ventricle in mitral regurgitation hearts than in normal controls {85 ± 39 vs.
27 ± 16 pglgm, p < O.Oll and ANG II correlated with LV end-diastolic wall
stress Ir = 0.75, P < 0.051. ACE activity increased in MR hearts compared
to controls (1.22 ± 0.46 vs. 3.55 ± 1.39 mUnitslgm, p < 0.05) and chymase
activity was also in MR hearts compared to controls (9.42 ± 4.6 vs. 19.81 ±
8.93 nmollgmlmin, p < 0.05). These results demonstrate significant eleva-
tion of intracardiac ANG II levels associated with increasing diastolic stress
and increasing intracardiac ACE and chymase activity. The parallel responses
of ACE and chymase activity in response to volume overload of the dog heart
suggest that the increased ANG II levels in this model are generated by ACE
and chymase. Further studies using selective inhibitors of these enzymes are
needed to establish an etiologic relationship between increased ACE activity
and left ventricular remodeling in this model.
To investigate the changes in myocardial glycolytic and fatty acid metabolism
during progression of ADR-induced heart failure, sixty five 8-weeks male S-D
rats were injected intraperitoneally with ADR (15 mgfkg) or equivalent vol-
ume of saline, divided into 6 times for 2-weeks. Rats were sacrificed and the
left ventricles were removed, at 1 day (ADR 10 group, Control 10 group),
at 3 weeks (ADR 3W group, Control 3W group) and at 6 weeks (ADR 6W
group, Control 6W group) after the last ADR or saline injection. By using
proton-MRS, we measured myocardial metabolites (lactate and alanine as
indices of glycolytic metabolism, and free carnitine as an index of fatty acid
metabolism). As an index of energy production, high energy phosphate (ATP)
in the myocardium was also measured by HPLC.
Results; The cumulative mortality rate was 0% in control groups and
48% in ADR-treated groups during observed period. The mortality rate was
abruptly increased 3 weeks after the last injection.
lactate alanine free carnitine ATP
Control 1D(n ~ 6) 11.85 ± 0.98 112±0.06 107 ± 0.08 8.52 ± 0.32
Control 3W In = 6) 11.22 ± 091 114±0.09 1.12±0.09 860 ± 038
Control 6W (n =4) 13.10 ± 168 158 ± 0.23 1.05 ± 0.12 8.90 ± 0.19
lactate. alanine, free carnitine, j..tmol/wet g. Alp, nmol/mg protein
No significant changes in tissue levels of lactate, alanine, free carnitine
and ATP were observed among Control groups
Maurizio Galderisi, Antonio Petrocelli, Mario Garofalo, Alfonso Alfieri, Oreste de
Divitiis. Clinical Methodology, University ofNaples, Italy
Although arterial hypertension is the main determinant of diastolic dysfunc-
tion, few data exist about the relations between 24-h BP profile and LV filling.
We examined Doppler echocardiography and ambulatory BP (ABP) in 101
subjects (60 men, 41 women, age 46.3 ± 9.9 years) free of cardiac drugs.
Subjects were excluded for coronary artery and valvular disease, heart fail-
ure and diabetes. Based on clinic BP levels 18 subjects were considered
